BioCardia Inc (BCDA)

[realfast95]

Trial due dates from last year's 10K


The CardiAMP Heart Failure Trial was initiated in Q4 2016, and the first patient treated in Q1 2017. The Data Safety Monitoring Board (DSMB) safety review of the 10 patient roll in cohort treated at three clinical sites was completed successfully in Q3 2017, and the trial is actively enrolling today at 10 clinical sites. Efficacy data from the primary endpoint in the open label roll in cohort are anticipated in second half of 2018. We anticipate that trial enrollment will be completed in the first half of 2019 and expect top line data will be available in the first half of 2020.